Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 199 entries
Sorted by: Best Match Show Resources per page
Influences of Dietary Added Sugar Consumption on Striatal Food-Cue Reactivity and Postprandial GLP-1 Response.

Frontiers in psychiatry

Dorton HM, Luo S, Monterosso JR, Page KA.
PMID: 29403396
Front Psychiatry. 2018 Jan 04;8:297. doi: 10.3389/fpsyt.2017.00297. eCollection 2017.

Sugar consumption in the United States exceeds recommendations from the American Heart Association. Overconsumption of sugar is linked to risk for obesity and metabolic disease. Animal studies suggest that high-sugar diets alter functions in brain regions associated with reward...

Cite
Dorton HM, Luo S, Monterosso JR, et al. Influences of Dietary Added Sugar Consumption on Striatal Food-Cue Reactivity and Postprandial GLP-1 Response. Front Psychiatry. 2018;8:297doi: 10.3389/fpsyt.2017.00297.
Dorton, H. M., Luo, S., Monterosso, J. R., & Page, K. A. (2017). Influences of Dietary Added Sugar Consumption on Striatal Food-Cue Reactivity and Postprandial GLP-1 Response. Frontiers in psychiatry, 8297. https://doi.org/10.3389/fpsyt.2017.00297
Dorton, Hilary M, et al. "Influences of Dietary Added Sugar Consumption on Striatal Food-Cue Reactivity and Postprandial GLP-1 Response." Frontiers in psychiatry vol. 8 (2017): 297. doi: https://doi.org/10.3389/fpsyt.2017.00297
Dorton HM, Luo S, Monterosso JR, Page KA. Influences of Dietary Added Sugar Consumption on Striatal Food-Cue Reactivity and Postprandial GLP-1 Response. Front Psychiatry. 2018 Jan 04;8:297. doi: 10.3389/fpsyt.2017.00297. eCollection 2017. PMID: 29403396; PMCID: PMC5777392.
Copy Download .nbib Format: NLM
Binding of Natural Peptide Ligands to the Neuropeptide Y5 Receptor.

Angewandte Chemie (International ed. in English)

Rudolf S, Kaempf K, Vu O, Meiler J, Beck-Sickinger AG, Coin I.
PMID: 34822209
Angew Chem Int Ed Engl. 2021 Nov 25; doi: 10.1002/anie.202108738. Epub 2021 Nov 25.

The binding mode of natural peptide ligands to the Y 5 G protein-coupled receptor (Y 5 R), an attractive therapeutic target for the treatment of obesity, is largely unknown. Here, we apply complementary biochemical and computational approaches, including scanning...

Cite
Rudolf S, Kaempf K, Vu O, et al. Binding of Natural Peptide Ligands to the Neuropeptide Y5 Receptor. Angew Chem Int Ed Engl. 2021;doi: 10.1002/anie.202108738.
Rudolf, S., Kaempf, K., Vu, O., Meiler, J., Beck-Sickinger, A. G., & Coin, I. (2021). Binding of Natural Peptide Ligands to the Neuropeptide Y5 Receptor. Angewandte Chemie (International ed. in English), . https://doi.org/10.1002/anie.202108738
Rudolf, Sarina, et al. "Binding of Natural Peptide Ligands to the Neuropeptide Y5 Receptor." Angewandte Chemie (International ed. in English) vol. (2021). doi: https://doi.org/10.1002/anie.202108738
Rudolf S, Kaempf K, Vu O, Meiler J, Beck-Sickinger AG, Coin I. Binding of Natural Peptide Ligands to the Neuropeptide Y5 Receptor. Angew Chem Int Ed Engl. 2021 Nov 25; doi: 10.1002/anie.202108738. Epub 2021 Nov 25. PMID: 34822209.
Copy Download .nbib Format: NLM
Blood Sampling From Rat Ileal Mesenteric Vein Revealed a Major Role of Dietary Protein in Meal-Induced GLP-1 Response.

Frontiers in endocrinology

Hira T, Sekishita M, Hara H.
PMID: 34149624
Front Endocrinol (Lausanne). 2021 Jun 02;12:689685. doi: 10.3389/fendo.2021.689685. eCollection 2021.

The present study was conducted to examine region-dependent glucagon-like peptide-1 (GLP-1) responses to "meal ingestion" under physiological (conscious and unrestrained) conditions using rats with a catheter inserted into either the portal vein (PV) or the ileal mesenteric vein (ILMV)....

Cite
Hira T, Sekishita M, Hara H. Blood Sampling From Rat Ileal Mesenteric Vein Revealed a Major Role of Dietary Protein in Meal-Induced GLP-1 Response. Front Endocrinol (Lausanne). 2021;12:689685doi: 10.3389/fendo.2021.689685.
Hira, T., Sekishita, M., & Hara, H. (2021). Blood Sampling From Rat Ileal Mesenteric Vein Revealed a Major Role of Dietary Protein in Meal-Induced GLP-1 Response. Frontiers in endocrinology, 12689685. https://doi.org/10.3389/fendo.2021.689685
Hira, Tohru, et al. "Blood Sampling From Rat Ileal Mesenteric Vein Revealed a Major Role of Dietary Protein in Meal-Induced GLP-1 Response." Frontiers in endocrinology vol. 12 (2021): 689685. doi: https://doi.org/10.3389/fendo.2021.689685
Hira T, Sekishita M, Hara H. Blood Sampling From Rat Ileal Mesenteric Vein Revealed a Major Role of Dietary Protein in Meal-Induced GLP-1 Response. Front Endocrinol (Lausanne). 2021 Jun 02;12:689685. doi: 10.3389/fendo.2021.689685. eCollection 2021. PMID: 34149624; PMCID: PMC8206781.
Copy Download .nbib Format: NLM
Anorexigenic Effects of Intermittent Hypoxia on the Gut-Brain Axis in Sleep Apnea Syndrome.

International journal of molecular sciences

Shobatake R, Ota H, Takahashi N, Ueno S, Sugie K, Takasawa S.
PMID: 35008784
Int J Mol Sci. 2021 Dec 29;23(1). doi: 10.3390/ijms23010364.

Sleep apnea syndrome (SAS) is a breathing disorder characterized by recurrent episodes of upper-airway collapse, resulting in intermittent hypoxia (IH) during sleep. Experimental studies with animals and cellular models have indicated that IH leads to attenuation of glucose-induced insulin...

Cite
Shobatake R, Ota H, Takahashi N, et al. Anorexigenic Effects of Intermittent Hypoxia on the Gut-Brain Axis in Sleep Apnea Syndrome. Int J Mol Sci. 2021;23(1)doi: 10.3390/ijms23010364.
Shobatake, R., Ota, H., Takahashi, N., Ueno, S., Sugie, K., & Takasawa, S. (2021). Anorexigenic Effects of Intermittent Hypoxia on the Gut-Brain Axis in Sleep Apnea Syndrome. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010364
Shobatake, Ryogo, et al. "Anorexigenic Effects of Intermittent Hypoxia on the Gut-Brain Axis in Sleep Apnea Syndrome." International journal of molecular sciences vol. 23,1 (2021). doi: https://doi.org/10.3390/ijms23010364
Shobatake R, Ota H, Takahashi N, Ueno S, Sugie K, Takasawa S. Anorexigenic Effects of Intermittent Hypoxia on the Gut-Brain Axis in Sleep Apnea Syndrome. Int J Mol Sci. 2021 Dec 29;23(1). doi: 10.3390/ijms23010364. PMID: 35008784; PMCID: PMC8745445.
Copy Download .nbib Format: NLM
The role of cholecystokinin and peptide YY in feed intake in Atlantic halibut (Hippoglossus hippoglossus) larvae.

Neuropeptides

Gomes AS, Lygre E, Harboe T, Zimmermann F, Jordal AO, Hamre K, Rønnestad I.
PMID: 34741845
Neuropeptides. 2021 Oct 28;91:102202. doi: 10.1016/j.npep.2021.102202. Epub 2021 Oct 28.

Control of appetite and feed intake in fish larvae are still largely unexplored. Two of the key players in controlling vertebrate's feed intake are cholecystokinin (CCK) and peptide YY (PYY). Here we investigated the mRNA expression of pyy, cck...

Cite
Gomes AS, Lygre E, Harboe T, et al. The role of cholecystokinin and peptide YY in feed intake in Atlantic halibut (Hippoglossus hippoglossus) larvae. Neuropeptides. 2021;91:102202doi: 10.1016/j.npep.2021.102202.
Gomes, A. S., Lygre, E., Harboe, T., Zimmermann, F., Jordal, A. O., Hamre, K., & Rønnestad, I. (2021). The role of cholecystokinin and peptide YY in feed intake in Atlantic halibut (Hippoglossus hippoglossus) larvae. Neuropeptides, 91102202. https://doi.org/10.1016/j.npep.2021.102202
Gomes, Ana S, et al. "The role of cholecystokinin and peptide YY in feed intake in Atlantic halibut (Hippoglossus hippoglossus) larvae." Neuropeptides vol. 91 (2021): 102202. doi: https://doi.org/10.1016/j.npep.2021.102202
Gomes AS, Lygre E, Harboe T, Zimmermann F, Jordal AO, Hamre K, Rønnestad I. The role of cholecystokinin and peptide YY in feed intake in Atlantic halibut (Hippoglossus hippoglossus) larvae. Neuropeptides. 2021 Oct 28;91:102202. doi: 10.1016/j.npep.2021.102202. Epub 2021 Oct 28. PMID: 34741845.
Copy Download .nbib Format: NLM
Effects of menstrual cycle on appetite-regulating hormones and energy intake in response to cycling exercise in physically active women.

Journal of applied physiology (Bethesda, Md. : 1985)

Kamemoto K, Yamada M, Matsuda T, Ogata H, Ishikawa A, Kanno M, Miyashita M, Sakamaki-Sunaga M.
PMID: 34882026
J Appl Physiol (1985). 2022 Jan 01;132(1):224-235. doi: 10.1152/japplphysiol.01117.2020. Epub 2021 Dec 09.

Although ample evidence supports the notion that an acute bout of endurance exercise performed at or greater than 70% of maximum oxygen uptake suppresses appetite partly through changes in appetite-regulating hormones, no study has directly compared the influence between...

Cite
Kamemoto K, Yamada M, Matsuda T, et al. Effects of menstrual cycle on appetite-regulating hormones and energy intake in response to cycling exercise in physically active women. J Appl Physiol (1985). 2021;132(1):224-235doi: 10.1152/japplphysiol.01117.2020.
Kamemoto, K., Yamada, M., Matsuda, T., Ogata, H., Ishikawa, A., Kanno, M., Miyashita, M., & Sakamaki-Sunaga, M. (2022). Effects of menstrual cycle on appetite-regulating hormones and energy intake in response to cycling exercise in physically active women. Journal of applied physiology (Bethesda, Md. : 1985), 132(1), 224-235. https://doi.org/10.1152/japplphysiol.01117.2020
Kamemoto, Kayoko, et al. "Effects of menstrual cycle on appetite-regulating hormones and energy intake in response to cycling exercise in physically active women." Journal of applied physiology (Bethesda, Md. : 1985) vol. 132,1 (2022): 224-235. doi: https://doi.org/10.1152/japplphysiol.01117.2020
Kamemoto K, Yamada M, Matsuda T, Ogata H, Ishikawa A, Kanno M, Miyashita M, Sakamaki-Sunaga M. Effects of menstrual cycle on appetite-regulating hormones and energy intake in response to cycling exercise in physically active women. J Appl Physiol (1985). 2022 Jan 01;132(1):224-235. doi: 10.1152/japplphysiol.01117.2020. Epub 2021 Dec 09. PMID: 34882026.
Copy Download .nbib Format: NLM
Ligilactobacillus Salivarius LCK11 Prevents Obesity by Promoting PYY Secretion to Inhibit Appetite and Regulating Gut Microbiota in C57BL/6J Mice.

Molecular nutrition & food research

Liang C, Zhou XH, Jiao YH, Guo MJ, Meng L, Gong PM, Lyu LZ, Niu HY, Wu YF, Chen SW, Han X, Zhang LW.
PMID: 34272917
Mol Nutr Food Res. 2021 Sep;65(17):e2100136. doi: 10.1002/mnfr.202100136. Epub 2021 Jul 17.

SCOPE: Obesity is a common disease worldwide and there is an urgent need for strategies to preventing obesity.METHODS AND RESULTS: The anti-obesity effect and mechanism of Ligilactobacillus salivarius LCK11 (LCK11) is studied using a C57BL/6J male mouse model in...

Cite
Liang C, Zhou XH, Jiao YH, et al. Ligilactobacillus Salivarius LCK11 Prevents Obesity by Promoting PYY Secretion to Inhibit Appetite and Regulating Gut Microbiota in C57BL/6J Mice. Mol Nutr Food Res. 2021;65(17):e2100136doi: 10.1002/mnfr.202100136.
Liang, C., Zhou, X. H., Jiao, Y. H., Guo, M. J., Meng, L., Gong, P. M., Lyu, L. Z., Niu, H. Y., Wu, Y. F., Chen, S. W., Han, X., & Zhang, L. W. (2021). Ligilactobacillus Salivarius LCK11 Prevents Obesity by Promoting PYY Secretion to Inhibit Appetite and Regulating Gut Microbiota in C57BL/6J Mice. Molecular nutrition & food research, 65(17), e2100136. https://doi.org/10.1002/mnfr.202100136
Liang, Cong, et al. "Ligilactobacillus Salivarius LCK11 Prevents Obesity by Promoting PYY Secretion to Inhibit Appetite and Regulating Gut Microbiota in C57BL/6J Mice." Molecular nutrition & food research vol. 65,17 (2021): e2100136. doi: https://doi.org/10.1002/mnfr.202100136
Liang C, Zhou XH, Jiao YH, Guo MJ, Meng L, Gong PM, Lyu LZ, Niu HY, Wu YF, Chen SW, Han X, Zhang LW. Ligilactobacillus Salivarius LCK11 Prevents Obesity by Promoting PYY Secretion to Inhibit Appetite and Regulating Gut Microbiota in C57BL/6J Mice. Mol Nutr Food Res. 2021 Sep;65(17):e2100136. doi: 10.1002/mnfr.202100136. Epub 2021 Jul 17. PMID: 34272917.
Copy Download .nbib Format: NLM
Peptide-YY.

Molecular metabolism

Boland BB, Laker RC, O'Brien S, Sitaula S, Sermadiras I, Nielsen JC, Barkholt P, Roostalu U, Hecksher-Sørensen J, Sejthen SR, Thorbek DD, Suckow A, Burmeister N, Oldham S, Will S, Howard VG, Gill BM, Newton P, Naylor J, Hornigold DC, Austin J, Lantier L, McGuinness OP, Trevaskis JL, Grimsby JS, Rhodes CJ.
PMID: 34781035
Mol Metab. 2021 Nov 12;101392. doi: 10.1016/j.molmet.2021.101392. Epub 2021 Nov 12.

OBJECTIVE: Obesity-linked type 2 diabetes (T2D) is a worldwide health concern and many novel approaches are being considered for its treatment and subsequent prevention of serious comorbidities. Co-administration of glucagon like peptide 1 (Fc-GLP-1) and peptide YYMETHODS: In this...

Cite
Boland BB, Laker RC, O'Brien S, et al. Peptide-YY. Mol Metab. 2021;101392doi: 10.1016/j.molmet.2021.101392.
Boland, B. B., Laker, R. C., O'Brien, S., Sitaula, S., Sermadiras, I., Nielsen, J. C., Barkholt, P., Roostalu, U., Hecksher-Sørensen, J., Sejthen, S. R., Thorbek, D. D., Suckow, A., Burmeister, N., Oldham, S., Will, S., Howard, V. G., Gill, B. M., Newton, P., Naylor, J., Hornigold, D. C., Austin, J., Lantier, L., McGuinness, O. P., Trevaskis, J. L., Grimsby, J. S., & Rhodes, C. J. (2021). Peptide-YY. Molecular metabolism, 101392. https://doi.org/10.1016/j.molmet.2021.101392
Boland, Brandon B, et al. "Peptide-YY." Molecular metabolism vol. (2021): 101392. doi: https://doi.org/10.1016/j.molmet.2021.101392
Boland BB, Laker RC, O'Brien S, Sitaula S, Sermadiras I, Nielsen JC, Barkholt P, Roostalu U, Hecksher-Sørensen J, Sejthen SR, Thorbek DD, Suckow A, Burmeister N, Oldham S, Will S, Howard VG, Gill BM, Newton P, Naylor J, Hornigold DC, Austin J, Lantier L, McGuinness OP, Trevaskis JL, Grimsby JS, Rhodes CJ. Peptide-YY. Mol Metab. 2021 Nov 12;101392. doi: 10.1016/j.molmet.2021.101392. Epub 2021 Nov 12. PMID: 34781035.
Copy Download .nbib Format: NLM
Effect of inulin-type fructans on appetite in patients with type 2 diabetes: a randomised controlled crossover trial.

Journal of nutritional science

Birkeland E, Gharagozlian S, Birkeland KI, Holm OKS, Thorsby PM, Aas AM.
PMID: 34589204
J Nutr Sci. 2021 Sep 10;10:e72. doi: 10.1017/jns.2021.70. eCollection 2021.

The aim of the study was to investigate the effect of prebiotic fibres on appetite-regulating hormones, subjective feeling of appetite and energy intake in subjects with type 2 diabetes. Data presented are secondary outcomes of a study investigating the...

Cite
Birkeland E, Gharagozlian S, Birkeland KI, et al. Effect of inulin-type fructans on appetite in patients with type 2 diabetes: a randomised controlled crossover trial. J Nutr Sci. 2021;10:e72doi: 10.1017/jns.2021.70.
Birkeland, E., Gharagozlian, S., Birkeland, K. I., Holm, O. K. S., Thorsby, P. M., & Aas, A. M. (2021). Effect of inulin-type fructans on appetite in patients with type 2 diabetes: a randomised controlled crossover trial. Journal of nutritional science, 10e72. https://doi.org/10.1017/jns.2021.70
Birkeland, Eline, et al. "Effect of inulin-type fructans on appetite in patients with type 2 diabetes: a randomised controlled crossover trial." Journal of nutritional science vol. 10 (2021): e72. doi: https://doi.org/10.1017/jns.2021.70
Birkeland E, Gharagozlian S, Birkeland KI, Holm OKS, Thorsby PM, Aas AM. Effect of inulin-type fructans on appetite in patients with type 2 diabetes: a randomised controlled crossover trial. J Nutr Sci. 2021 Sep 10;10:e72. doi: 10.1017/jns.2021.70. eCollection 2021. PMID: 34589204; PMCID: PMC8453458.
Copy Download .nbib Format: NLM
Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity.

Pharmacological research

Kleftaki SA, Simati S, Amerikanou C, Gioxari A, Tzavara C, Zervakis GI, Kalogeropoulos N, Kokkinos A, Kaliora AC.
PMID: 34798266
Pharmacol Res. 2021 Nov 16;175:105979. doi: 10.1016/j.phrs.2021.105979. Epub 2021 Nov 16.

The aim of this study was to examine potential postprandial benefits of Pleurotus eryngii in nineteen volunteers with metabolically unhealthy obesity. An acute, randomized, crossover-designed trial comparing a meal with Pleurotus eryngii and a control meal was performed. The...

Cite
Kleftaki SA, Simati S, Amerikanou C, et al. Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacol Res. 2021;175:105979doi: 10.1016/j.phrs.2021.105979.
Kleftaki, S. A., Simati, S., Amerikanou, C., Gioxari, A., Tzavara, C., Zervakis, G. I., Kalogeropoulos, N., Kokkinos, A., & Kaliora, A. C. (2021). Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacological research, 175105979. https://doi.org/10.1016/j.phrs.2021.105979
Kleftaki, Stamatia-Angeliki, et al. "Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity." Pharmacological research vol. 175 (2021): 105979. doi: https://doi.org/10.1016/j.phrs.2021.105979
Kleftaki SA, Simati S, Amerikanou C, Gioxari A, Tzavara C, Zervakis GI, Kalogeropoulos N, Kokkinos A, Kaliora AC. Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacol Res. 2021 Nov 16;175:105979. doi: 10.1016/j.phrs.2021.105979. Epub 2021 Nov 16. PMID: 34798266.
Copy Download .nbib Format: NLM
Enterohormone therapy for short bowel syndrome.

Current opinion in endocrinology, diabetes, and obesity

Verbiest A, Wauters L, Vanuytsel T, Storm V, Reinwand DA.
PMID: 35034035
Curr Opin Endocrinol Diabetes Obes. 2022 Jan 14; doi: 10.1097/MED.0000000000000710. Epub 2022 Jan 14.

PURPOSE OF THIS REVIEW: Short bowel syndrome (SBS) patients are at risk to develop intestinal failure when the decreased absorption of macronutrients, water, and electrolytes necessitates parenteral support for survival. The adverse effects of SBS and parenteral support negatively...

Cite
Verbiest A, Wauters L, Vanuytsel T, et al. Enterohormone therapy for short bowel syndrome. Curr Opin Endocrinol Diabetes Obes. 2022;doi: 10.1097/MED.0000000000000710.
Verbiest, A., Wauters, L., Vanuytsel, T., Storm, V., & Reinwand, D. A. (2022). Enterohormone therapy for short bowel syndrome. Current opinion in endocrinology, diabetes, and obesity, . https://doi.org/10.1097/MED.0000000000000710
Verbiest, Astrid, et al. "Enterohormone therapy for short bowel syndrome." Current opinion in endocrinology, diabetes, and obesity vol. (2022). doi: https://doi.org/10.1097/MED.0000000000000710
Verbiest A, Wauters L, Vanuytsel T, Storm V, Reinwand DA. Enterohormone therapy for short bowel syndrome. Curr Opin Endocrinol Diabetes Obes. 2022 Jan 14; doi: 10.1097/MED.0000000000000710. Epub 2022 Jan 14. PMID: 35034035.
Copy Download .nbib Format: NLM
Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity.

Pharmacological research

Kleftaki SA, Simati S, Amerikanou C, Gioxari A, Tzavara C, Zervakis GI, Kalogeropoulos N, Kokkinos A, Kaliora AC.
PMID: 34798266
Pharmacol Res. 2021 Nov 16;175:105979. doi: 10.1016/j.phrs.2021.105979. Epub 2021 Nov 16.

The aim of this study was to examine potential postprandial benefits of Pleurotus eryngii in nineteen volunteers with metabolically unhealthy obesity. An acute, randomized, crossover-designed trial comparing a meal with Pleurotus eryngii and a control meal was performed. The...

Cite
Kleftaki SA, Simati S, Amerikanou C, et al. Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacol Res. 2021;175:105979doi: 10.1016/j.phrs.2021.105979.
Kleftaki, S. A., Simati, S., Amerikanou, C., Gioxari, A., Tzavara, C., Zervakis, G. I., Kalogeropoulos, N., Kokkinos, A., & Kaliora, A. C. (2021). Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacological research, 175105979. https://doi.org/10.1016/j.phrs.2021.105979
Kleftaki, Stamatia-Angeliki, et al. "Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity." Pharmacological research vol. 175 (2021): 105979. doi: https://doi.org/10.1016/j.phrs.2021.105979
Kleftaki SA, Simati S, Amerikanou C, Gioxari A, Tzavara C, Zervakis GI, Kalogeropoulos N, Kokkinos A, Kaliora AC. Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacol Res. 2021 Nov 16;175:105979. doi: 10.1016/j.phrs.2021.105979. Epub 2021 Nov 16. PMID: 34798266.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 199 entries